9-135664750-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001393661.1(LCN9):c.262G>A(p.Val88Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000128 in 1,598,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001393661.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCN9 | NM_001393661.1 | c.262G>A | p.Val88Met | missense_variant | 3/6 | ENST00000619315.2 | NP_001380590.1 | |
LCN9 | NR_171893.1 | n.275G>A | non_coding_transcript_exon_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCN9 | ENST00000619315.2 | c.262G>A | p.Val88Met | missense_variant | 3/6 | 1 | NM_001393661.1 | ENSP00000482296 | P1 | |
LCN9 | ENST00000430290.6 | n.248G>A | non_coding_transcript_exon_variant | 3/6 | 5 | |||||
LCN9 | ENST00000277526.8 | c.262G>A | p.Val88Met | missense_variant, NMD_transcript_variant | 3/6 | 5 | ENSP00000277526 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000813 AC: 18AN: 221272Hom.: 0 AF XY: 0.000100 AC XY: 12AN XY: 119696
GnomAD4 exome AF: 0.000133 AC: 193AN: 1446368Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 87AN XY: 718064
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74462
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at